乳房植入物疾病及其共病条件的系统综述与Meta分析
该系统综述与Meta分析于2024年9月24日检索五个数据库,纳入48项研究、7045例乳房植入物患者。3444例(49%)出现常被归类为「乳房植入物疾病」的症状群,409例(6%)诊断共病自身免疫病。出现BII症状的患者中51%有其他可解释诊断或病因。
要点
- 7045例乳房植入物患者中3444例(49%)出现BII症状群。
- 2425例(34%)报告关节痛和/或肌痛,1685例(24%)报告疲劳和/或不适。
- 出现BII症状的患者中51%有其他可解释诊断或病因,妨碍BII诊断。
核心结论
- 出现一种或多种BII症状的患者中,51%有其他可解释诊断或病因,妨碍BII诊断。
- 这些发现凸显需要更多研究BII的病因、诊断和管理,并改进患者教育与随访方案。
研究设计与样本
- 系统综述与Meta分析,于2024年9月24日检索EMBASE、PubMed、Scopus、Web of Science和Google Scholar。
- 纳入标准要求同行评议原创研究中探讨BII与自身免疫性疾病的关系。
- 由两名研究者独立进行筛选、提取和分析。
- 从1362篇报告中选出48篇文章分析,研究在全球开展,纳入7045例乳房植入物(双侧或单侧)患者。
主要发现
- 7045例患者中3444例(49%)出现常被归类为「乳房植入物疾病」的症状群。
- 2425例(34%)报告关节痛和/或肌痛,1477例(21%)报告认知功能障碍如脑雾和/或注意力丧失,1685例(24%)报告疲劳和/或不适。
- 409例(6%)诊断共病自身免疫病,1005例(14%)有既往或当前吸烟史。
- 报告BII的可能性、恶性肿瘤史、接受取出植入物的可能性与取出植入物后症状改善或完全缓解之间存在显著关联。
- 出现一种或多种BII症状的患者中,51%有其他可解释诊断或病因,妨碍BII诊断。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Despite growing interest, there is scarce literature that describes the comorbid conditions and presenting symptoms that can manifest with or potentially as breast implant illness (BII). This review aims to address this gap. METHODS: A systematic search was conducted on September 24, 2024, using EMBASE, PubMed, Scopus, Web of Science, and Google Scholar. Inclusion criteria required the exploration of BII in relation to autoimmune disorders in peer-reviewed original research. Two investigators independently conducted the screening, extraction, and analysis. RESULTS: Of the 1362 reports identified, 48 articles were selected for analysis. These studies were conducted globally and included 7045 patients with breast implants (bilateral or unilateral). Of these, 3444 patients (49%) presented with the constellations of symptoms often classified as "breast implant illness." 2425 patients (34%) reported complaints of arthralgia and/or myalgia, 1477 patients (21%) reported cognitive dysfunction such as brain fog and/or loss of concentration, and 1685 patients (24%) reported fatigue and/or malaise. Additionally, 409 patients (6%) had a diagnosed comorbid autoimmune condition, while 1005 (14%) had a history of former or active smoking. Significant associations were found between likelihood of reporting BII, history of malignancy, likelihood of undergoing explantation, and symptom improvement or complete resolution postexplantation. CONCLUSION: Among the patients that presented with one or more symptoms of BII, 51% had other explainable diagnoses or etiologies for their symptoms that precluded the diagnosis of BII. These findings highlight the need for more research into BII etiology, diagnosis, and management and improved patient education and follow-up protocols.
引用
- Trabilsy M, Haider SA, Borna S, et al. Exploring breast implant illness and its comorbid conditions: A systematic review & meta-analysis. J Plast Reconstr Aesthet Surg. 2025. PMID: 40203657. doi:10.1016/j.bjps.2025.03.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。